Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia

Dongsheng Zhang; Wenjuan Tang; Haitao Niu; William Tse; Hai-Bin Ruan; Helmut Dolznig; Thomas Knösel; Friedrich Karl-Heinz; Madeleine Themanns; Jiang Wang; Mingquan Song; Lee Denson; Lukas Kenner; Richard Moriggl; Yi Zheng; Xiaonan Han

doi:10.1016/j.gendis.2022.11.024

您当前的位置：

首页 >

文章列表页 >

Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia

Full Length Articles | 更新时间：2024-02-04

- Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
- Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
- Genes & Diseases 2024年1卷第1期页码：413-429
- 作者机构：
  
  1. Division of Hematology and Oncology, Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center (MHMC), Case Western Reserve University (CWRU), School of Medicine,OH,Cleveland,USA,44109
  2. Cancer Genomics and Epigenomics Program, Case Comprehensive Cancer Center, Case Western Reserve University (CWRU),OH,Cleveland,USA,44106
  3. Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC),OH,Cincinnati,USA,45229
  4. Children's Hospital of Fudan University,Shanghai,China,201102
  5. School of Medicine, Jinan University,Guangdong,Guangzhou,China,510632
  6. Laboratory Animal Science (ILAS), Chinese Academy of Medical Science (CAMS) and Peking Union Medical College (PUMC),Beijing,China,100006
  7. Department of Integrative Biology and Physiology, University of Minnesota Medical School,MI,Minneapolis,USA,55455
  8. Institute of Medical Genetics, Medical University of Vienna,Vienna,Austria,1040
  9. Institute of Pathology, Ludwig-Maximilians-University Munich,Munich,Germany,80539
  10. Institute of Biochemistry II, University Hospital Jena, Jena,Germany,07743
  11. Laboratory Animal Pathology, University of Veterinary Medicine Vienna,Vienna,Austria,1210
  12. Department of Pathology, University of Cincinnati,OH,Cincinnati,USA,45221
  13. Department of Gastroenterology, The Affiliated Hospital of Qingdao University,Shandong,Qingdao,China,266005
  14. Department of Pathology, Medical University of Vienna,Vienna,Austria,1040
  15. Ludwig Boltzmann Institute for Cancer Research,Vienna,Austria,1090
  16. Medical University of Vienna,Vienna,Austria,1040
  17. Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna,Vienna,Austria,1210
  18. Division of Experimental Hematology, CCHMC,OH,Cincinnati,USA,45229
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2022.11.024
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-1-1，
扫描看全文
Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia[J]. Genes & Diseases, 2024,1(1):413-429.

Dongsheng Zhang, Wenjuan Tang, Haitao Niu, et al. Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia[J]. Genes & Diseases, 2024,1(1):413-429.
Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia[J]. Genes & Diseases, 2024,1(1):413-429. DOI： 10.1016/j.gendis.2022.11.024.

Dongsheng Zhang, Wenjuan Tang, Haitao Niu, et al. Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia[J]. Genes & Diseases, 2024,1(1):413-429. DOI： 10.1016/j.gendis.2022.11.024.

摘要

Abstract

CDC42 controls intestinal epithelial (IEC) stem cell (IESC) division. How aberrant CDC42 initiates intestinal inflammation or neoplasia is unclear. We utilized models of inflammatory bowel diseases (IBD)

colorectal cancer

aging

and IESC injury to determine the loss of intestinal

Cdc42

upon inflammation and neoplasia. Intestinal specimens were collected to determine the levels of CDC42 in IBD or colorectal cancer.

Cdc42

floxed mice were crossed with

Villin

-Cre

Villin

-CreER

and/or

Lgr5-

eGFP-IRES-CreER

Bmi1

-CreER

mice to generate

Cdc42

deficient mice. Irradiation

colitis

aging

and intestinal organoid were used to evaluate CDC42 upon mucosal inflammation

IESC/progenitor regenerative capacity

and IEC repair. Our studies revealed that increased CDC42 in colorectal cancer correlated with lower survival; in contrast

lower levels of CDC42 were found in the inflamed IBD colon. Colonic

Cdc42

depletion significantly reduced Lgr5

IESCs

increased progenitors' hyperplasia

and induced mucosal inflammation

which led to crypt dysplasia. Colonic

Cdc42

depletion markedly enhanced irradiation- or chemical-induced colitis. Depletion or inhibition of

Cdc42

reduced colonic Lgr5

IESC regeneration. In conclusion

depletion of

Cdc42

reduces the IESC regeneration and IEC repair

leading to prolonged mucosal inflammation. Constitutive monogenic loss of

Cdc42

induces mucosal inflammation

which could result in intestinal neoplasia in the context of aging.

关键词

Keywords

Cell division cycle 42 (CDC42)ColitisColorectal cancer (CRC)Inflammatory bowel diseases (IBD)Intestinal epithelial cell (IEC)Intestinal epithelial stem cell (IESC)Irradiation

references

1 K. Hirayama, K. ItohHuman flora-associated (HFA) animals as a model for studying the role of intestinal flora in human health and disease Curr Issues Intest Microbiol, 6 (2) (2005), pp. 69-75

2 S.C. Shah, S.H. ItzkowitzColorectal cancer in inflammatory bowel disease: mechanisms and management Gastroenterology, 162 (3) (2022), pp. 715-730

3 G. Bouma, W. StroberThe immunological and genetic basis of inflammatory bowel disease Nat Rev Immunol, 3 (7) (2003), pp. 521-533

4 X.C. He, T. Yin, J.C. Grindley, et al.PTEN-deficient intestinal stem cells initiate intestinal polyposis Nat Genet, 39 (2) (2007), pp. 189-198

5 M. Quante, T.C. WangStem cells in gastroenterology and hepatology Nat Rev Gastroenterol Hepatol, 6 (12) (2009), pp. 724-737

6 S.B. HanauerInflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities Inflamm Bowel Dis, 12 (Suppl 1) (2006), pp. S3-S9

7 F.A. Farraye, R.D. Odze, J. Eaden, et al.AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology, 138 (2) (2010), pp. 746-774

8 C.M. Dekaney, J.M. Rodriguez, M.C. Graul, et al.Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum Gastroenterology, 129 (5) (2005), pp. 1567-1580

9 J.R. Spence, C.N. Mayhew, S.A. Rankin, et al.Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro Nature, 470 (7332) (2011), pp. 105-109

10 D. Lin, A.S. Edwards, J.P. Fawcett, et al.A mammalian PAR-3-PAR-6 complex implicated in Cdc 42/Rac 1 and aPKC signalling and cell polarity Nat Cell Biol, 2 (8) (2000), pp. 540-547

11 G. Kesavan, F.W. Sand, T.U. Greiner, et al.Cdc42-mediated tubulogenesis controls cell specification Cell, 139 (4) (2009), pp. 791-801

12 J. Melendez, M. Liu, L. Sampson, et al.Cdc42 coordinates proliferation, polarity, migration, and differentiation of small intestinal epithelial cells in mice Gastroenterology, 145 (4) (2013), pp. 808-819

13 T. Gómez Del Pulgar, F. Valdés-Mora, E. Bandrés, et al.Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism Int J Oncol, 33 (1) (2008), pp. 185-193

14 N.A. Al-Tassan, N. Whiffin, F.J. Hosking, et al.A new GWAS and meta-analysis with 1000 Genomes imputation identifies novel risk variants for colorectal cancer Sci Rep, 5 (2015), Article 10442

15 R. Sakamori, S. Das, S. Yu, et al.Cdc42 and Rab8a are critical for intestinal stem cell division, survival, and differentiation in mice J Clin Invest, 122 (3) (2012), pp. 1052-1065

16 N. BarkerAdult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration Nat Rev Mol Cell Biol, 15 (1) (2014), pp. 19-33

17 H.J. Snippert, L.G. van der Flier, T. Sato, et al.Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells Cell, 143 (1) (2010), pp. 134-144

18 J.H. van Es, T. Sato, M. van de Wetering, et al.Dll 1+ secretory progenitor cells revert to stem cells upon crypt damage Nat Cell Biol, 14 (10) (2012), pp. 1099-1104

19 S. Schwitalla, A.A. Fingerle, P. Cammareri, et al.Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties Cell, 152 (1–2) (2013), pp. 25-38

20 Y. Cui, G. Riedlinger, K. Miyoshi, et al.Inactivation of Stat 5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation Mol Cell Biol, 24 (18) (2004), pp. 8037-8047

21 F. el Marjou, K.P. Janssen, B.H. Chang, et al.Tissue-specific and inducible cre-mediated recombination in the gut epithelium Genesis, 39 (3) (2004), pp. 186-193

22 T.H. Kim, S. Escudero, R.A. ShivdasaniIntact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells Proc Natl Acad Sci U S A, 109 (10) (2012), pp. 3932-3937

23 C. Gordziel, J. Bratsch, R. Moriggl, et al.Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma Br J Cancer, 109 (1) (2013), pp. 138-146

24 M. Ahadi, A. Sokolova, I. Brown, et al.The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment Pathology, 53 (4) (2021), pp. 454-461

25 T. Knösel, Y. Chen, S. Hotovy, et al.Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma Int J Colorectal Dis, 27 (11) (2012), pp. 1391-1399

26 M. Zhao, X. Xiong, K. Ren, et al.Deficiency in intestinal epithelial O-GlcNAcylation predisposes to gut inflammation EMBO Mol Med, 10 (8) (2018), Article e8736

27 D. Vignjevic, M. Schoumacher, N. Gavert, et al.Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer Cancer Res, 67 (14) (2007), pp. 6844-6853

28 S. Anderson, K.R. Poudel, M. Roh-Johnson, et al.MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation Proc Natl Acad Sci U S A, 113 (37) (2016), pp. E5481-E5490

29 A. Pribluda, E. Elyada, Z. Wiener, et al.A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism Cancer Cell, 24 (2) (2013), pp. 242-256

30 S. Gilbert, R. Zhang, L. Denson, et al.Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation EMBO Mol Med, 4 (2) (2012), pp. 109-124

31 S. Gilbert, H. Nivarthi, C.N. Mayhew, et al.Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration Stem Cell Rep, 4 (2) (2015), pp. 209-225

32 E. Sangiorgi, M.R. CapecchiBmi1 is expressed in vivo in intestinal stem cells Nat Genet, 40 (7) (2008), pp. 915-920

33 K.S. Yan, L.A. Chia, X. Li, et al.The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations Proc Natl Acad Sci U S A, 109 (2) (2012), pp. 466-471

34 H.R. Withers, M.M. ElkindMicrocolony survival assay for cells of mouse intestinal mucosa exposed to radiation Int J Radiat Biol Relat Stud Phys Chem Med, 17 (3) (1970), pp. 261-267

35 R.K. Montgomery, D.L. Carlone, C.A. Richmond, et al.Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells Proc Natl Acad Sci U S A, 108 (1) (2011), pp. 179-184

36 T. Sato, D.E. Stange, M. Ferrante, et al.Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium Gastroenterology, 141 (5) (2011), pp. 1762-1772

37 S.J.A. Buczacki, H.I. Zecchini, A.M. Nicholson, et al.Intestinal label-retaining cells are secretory precursors expressing Lgr5 Nature, 495 (7439) (2013), pp. 65-69

38 T.E. Adolph, M.F. Tomczak, L. Niederreiter, et al.Paneth cells as a site of origin for intestinal inflammation Nature, 503 (7475) (2013), pp. 272-276

39 R.A. Risques, L.A. Lai, T.A. Brentnall, et al.Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage Gastroenterology, 135 (2) (2008), pp. 410-418

40 R. Sakamori, S. Yu, X. Zhang, et al.CDC42 inhibition suppresses progression of incipient intestinal tumors Cancer Res, 74 (19) (2014), pp. 5480-5492

41 E.H. Schroeter, J.A. Kisslinger, R. KopanNotch-1 signalling requires ligand-induced proteolytic release of intracellular domain Nature, 393 (6683) (1998), pp. 382-386

42 T. Sato, R.G. Vries, H.J. Snippert, et al.Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche Nature, 459 (7244) (2009), pp. 262-265

43 J. Terzić, S. Grivennikov, E. Karin, et al.Inflammation and colon cancer Gastroenterology, 138 (6) (2010), pp. 2101-2114

44 T. Nakaya, S. Ogawa, I. Manabe, et al.KLF5 regulates the integrity and oncogenicity of intestinal stem cells Cancer Res, 74 (10) (2014), pp. 2882-2891

45 C.D. Wells, J.P. Fawcett, A. Traweger, et al.A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells Cell, 125 (3) (2006), pp. 535-548

46 L. Van Aelst, M. SymonsRole of Rho family GTPases in epithelial morphogenesis Genes Dev, 16 (9) (2002), pp. 1032-1054

47 M. Georgiou, E. Marinari, J. Burden, et al.Cdc42, Par6, and aPKC regulate Arp2/3-mediated endocytosis to control local adherens junction stability Curr Biol, 18 (21) (2008), pp. 1631-1638

48 A.L. Bishop, A. HallRho GTPases and their effector proteins Biochem J, 348 (Pt 2) (2000), pp. 241-255

49 C. Lv, X. Zhao, H. Gu, et al.Involvement of activated Cdc42 Kinase 1 in colitis and colorectal neoplasms Med Sci Mon Int Med J Exp Clin Res, 22 (2016), pp. 4794-4802

50 K. Zins, S. Gunawardhana, T. Lucas, et al.Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity J Transl Med, 11 (2013), p. 295

51 J. van Hengel, P. D'Hooge, B. Hooghe, et al.Continuous cell injury promotes hepatic tumorigenesis in Cdc42-deficient mouse liver Gastroenterology, 134 (3) (2008), pp. 781-792

52 X. Wu, F. Quondamatteo, T. Lefever, et al.Cdc 42 controls progenitor cell differentiation and beta-catenin turnover in skin Genes Dev, 20 (5) (2006), pp. 571-585

53 A. Walther, E. Johnstone, C. Swanton, et al.Genetic prognostic and predictive markers in colorectal cancer Nat Rev Cancer, 9 (7) (2009), pp. 489-499

54 H. Rajagopalan, A. Bardelli, C. Lengauer, et al.Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status Nature, 418 (6901) (2002), p. 934

55 K.R. Cho, B. VogelsteinGenetic alterations in the adenoma--carcinoma sequence Cancer, 70 (6 Suppl) (1992), pp. 1727-1731

56 A. Russo, V. Bazan, B. Iacopetta, et al.The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment J Clin Oncol, 23 (30) (2005), pp. 7518-7528

57 N. Barker, R.A. Ridgway, J.H. van Es, et al.Crypt stem cells as the cells-of-origin of intestinal cancer Nature, 457 (7229) (2009), pp. 608-611

58 Z. Zhang, F. Zhang, A.K. Davis, et al.CDC42 controlled apical-basal polarity regulates intestinal stem cell to transit amplifying cell fate transition via YAP-EGF-mTOR signaling Cell Rep, 38 (2) (2022), Article 110009

59 J. Schuijers, L.G. van der Flier, J. van Es, et al.Robust cre-mediated recombination in small intestinal stem cells utilizing the Olfm4 locus Stem Cell Rep, 3 (2) (2014), pp. 234-241

60 N. Barker, J.H. van Es, J. Kuipers, et al.Identification of stem cells in small intestine and colon by marker gene Lgr5 Nature, 449 (7165) (2007), pp. 1003-1007

61 C. Crosnier, D. Stamataki, J. LewisOrganizing cell renewal in the intestine: stem cells, signals and combinatorial control Nat Rev Genet, 7 (5) (2006), pp. 349-359

62 V. Korinek, N. Barker, P.J. Morin, et al.Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma Science, 275 (5307) (1997), pp. 1784-1787

63 J.H. van Es, M.E. van Gijn, O. Riccio, et al.Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells Nature, 435 (7044) (2005), pp. 959-963

64 M.R. Junttila, W. Mao, X. Wang, et al.Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer Sci Transl Med, 7 (314) (2015), p. 314ra186

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Protective effects of IRG1/itaconate on acute colitis through the inhibition of gasdermins-mediated pyroptosis and inflammation response

Identification of inflammatory factor-related genes associated with the prognosis and immune cell infiltration in colorectal cancer patients

Recent advances in chronic granulomatous disease